Arkolith/Insider Trading/TMBR/Form 4

Rome Zachary

DirectorTimber Pharmaceuticals, Inc. (TMBR) · full profile →Form 4 · filed Apr 15, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2022Option exercise(M)79K$0.01$79379K
Mar 4, 2022Tax withholding(F)20K$0.28$5K60K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2022Option exercise(M)79K—$00
Mar 4, 2022Disposed to issuer(D)53K—$079K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-046471) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML